These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15618957)

  • 1. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.
    Lanciotti M; Dufour C; Corral L; Di Michele P; Pigullo S; De Rossi G; Basso G; Leszl A; Luciani M; Lo Nigro L; Micalizzi C; Valsecchi MG; Biondi A; Haupt R
    Leukemia; 2005 Feb; 19(2):214-6. PubMed ID: 15618957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.
    Smith MT; Wang Y; Skibola CF; Slater DJ; Lo Nigro L; Nowell PC; Lange BJ; Felix CA
    Blood; 2002 Dec; 100(13):4590-3. PubMed ID: 12393620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators.
    Wiemels JL; Pagnamenta A; Taylor GM; Eden OB; Alexander FE; Greaves MF
    Cancer Res; 1999 Aug; 59(16):4095-9. PubMed ID: 10463613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
    Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
    Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
    Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
    Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan.
    Eguchi-Ishimae M; Eguchi M; Ishii E; Knight D; Sadakane Y; Isoyama K; Yabe H; Mizutani S; Greaves M
    Haematologica; 2005 Nov; 90(11):1511-5. PubMed ID: 16266898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis.
    Guha N; Chang JS; Chokkalingam AP; Wiemels JL; Smith MT; Buffler PA
    Am J Epidemiol; 2008 Dec; 168(11):1221-32. PubMed ID: 18945694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution.
    de Aguiar Gonçalves BA; Vasconcelos GM; Thuler LC; Andrade C; Faro A; Pombo-de-Oliveira MS; ; Emerenciano M; de Camargo B; Bernstain L; Neves CC; Agareno JM; de Carvalho LM; Araújo FN; de Brito NP; Magalhães IQ; Cordoba JC; Pimenta F; Gadelha A; Cartaxo E; Basegio RM; Mnayarji A; Souza MS; Arencibia A; Melaragno R; Cóser VM; Lafayete TC; Koifman S
    Cancer Causes Control; 2012 Nov; 23(11):1811-9. PubMed ID: 22976839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
    Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
    Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of various MLL gene aberrations that lead to MLL gene mutation in patients with acute lymphoblastic leukemia (ALL) and infants with acute leukemia.
    Pais A; Amare Kadam P; Raje G; Sawant M; Kabre S; Jain H; Advani S; Banavali S
    Leuk Res; 2005 May; 29(5):517-26. PubMed ID: 15755504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia.
    Infante-Rivard C; Vermunt JK; Weinberg CR
    Am J Epidemiol; 2007 Jun; 165(11):1248-54. PubMed ID: 17332311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of GSTT1, GSTM1 and NQO1 (609C>T) in Filipino children with ALL (acute lymphoblastic leukaemia).
    Rimando MG; Chua MN; Yuson Ed; de Castro-Bernas G; Okamoto T
    Biosci Rep; 2008 Jun; 28(3):117-24. PubMed ID: 18444911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
    Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
    Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
    Ramakers-van Woerden NL; Beverloo HB; Veerman AJ; Camitta BM; Loonen AH; van Wering ER; Slater RM; Harbott J; den Boer ML; Ludwig WD; Haas OA; Janka-Schaub GE; Pieters R
    Leukemia; 2004 Mar; 18(3):521-9. PubMed ID: 14712291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of p16 and p15 genes in acute leukemia with MLL gene rearrangements and their correlation with clinical features.
    Ohnishi H; Guo SX; Ida K; Taki T; Naritaka S; Bessho F; Yanagisawa M; Hanada R; Eguchi M; Kamada N; Kita K; Yamamori S; Hayashi Y
    Leukemia; 1997 Dec; 11(12):2120-4. PubMed ID: 9447829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes.
    Kohlmann A; Schoch C; Dugas M; Schnittger S; Hiddemann W; Kern W; Haferlach T
    Leukemia; 2005 Jun; 19(6):953-64. PubMed ID: 15815718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the MLL breakpoint cluster region (BCR).
    Echlin-Bell DR; Smith LL; Li L; Strissel PL; Strick R; Gupta V; Banerjee J; Larson R; Relling MV; Raimondi SC; Hayashi Y; Taki T; Zeleznik-Le N; Rowley JD
    Hum Genet; 2003 Jul; 113(1):80-91. PubMed ID: 12665971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
    Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
    J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age.
    Behm FG; Raimondi SC; Frestedt JL; Liu Q; Crist WM; Downing JR; Rivera GK; Kersey JH; Pui CH
    Blood; 1996 Apr; 87(7):2870-7. PubMed ID: 8639906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia.
    Woo HY; Kim DW; Park H; Seong KW; Koo HH; Kim SH
    J Korean Med Sci; 2005 Feb; 20(1):36-41. PubMed ID: 15716599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.